📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials. (2019)

First Author: Andersen KM

Attributed to: MICA: Treatment According to Response in Giant cEll arTeritis (TARGET) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3899/jrheum.181123

PubMed Identifier: 30647191

Publication URI: http://europepmc.org/abstract/MED/30647191

Type: Journal Article/Review

Volume: 46

Parent Publication: The Journal of rheumatology

Issue: 8

ISSN: 0315-162X